Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.CCR-20-1876
Eur Urol Oncol. 2020 Oct 23:S2588-9311(20)30167-X.
doi: 10.1016/j.euo.2020.10.002.
Online ahead of print.
1 Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan. Electronic address: sfunada@kuhp.kyoto-u.ac.jp.
2 Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan; Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.
3 Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.